Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line

Figure 2

Effect of HDAC and PARP inhibitors combination on SW1736 cell viability. Cells were treated for 72 h with SAHA 1 μM and PJ34 15 μM, alone or in combination. CellTiter-Blue Cell Viability assay was performed as described in Section 2. Bars indicate the percentage of viable cells versus controls (untreated cells) and represent means ± SD of four experiments. * indicates values significantly different compared to all other conditions.